clodronic acid has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, A; Heidenreich, A; Jakob, T; Kuhr, K; Macherey, S; Monsef, I; Skoetz, N; Tesfamariam, YM | 1 |
| Hong, JH; Jamieson, C; Kim, IY; Kim, J; Kim, WJ; Kwon, SJ; Kwon, YS; Lee, GT; Lee, N | 1 |
1 review(s) available for clodronic acid and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
Topics: Adult; Alendronate; Antineoplastic Agents, Hormonal; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Denosumab; Diphosphonates; Etidronic Acid; Humans; Male; Network Meta-Analysis; Pamidronate; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Randomized Controlled Trials as Topic; RANK Ligand; Risedronic Acid; Zoledronic Acid | 2020 |
1 other study(ies) available for clodronic acid and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages.
Topics: Aged; Animals; Bone Morphogenetic Protein 6; Cell Line, Tumor; Chemokine CCL2; Clodronic Acid; Gene Expression Regulation, Neoplastic; Humans; Macrophages; Male; MAP Kinase Signaling System; Mice; Middle Aged; Neoplasm Transplantation; Prostatic Neoplasms, Castration-Resistant; Tissue Array Analysis; Up-Regulation; Wnt-5a Protein | 2018 |